We are live on
!
Find out more
GENE
Genetic Technologies Ltd.
GENE
GENE
Delisted
GENE was delisted on the 16th of October, 2024.
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
VKH
1
Virtu KCG Holdings
New York
| $27K | -$42.4K | -355 | -58% |
|
2
Citadel Advisors
Miami,
Florida
| $20K | -$33.4K | -279 | -60% |
|
3
Renaissance Technologies
New York
| $19K | +$21.5K | +180 | New |
|
|
ARTA
4
A.R.T. Advisors
New York
| $14K | -$2.15K | -18 | -12% |
|
|
APU
5
Alpine Partners USVI
St. Thomas,
U.S. Virgin Islands
| $12K | – | – | – |
|
|
CIM
6
Calvert Investment Management
Bethesda,
Maryland
| $11K | +$239 | +2 | +2% |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $4K | -$10.3K | -86 | -67% |
|
8
Citigroup
New York
| $2K | +$1.2K | +10 | +200% |
|
9
Group One Trading
Chicago,
Illinois
| $1K | -$598 | -5 | -33% |
|
10
Morgan Stanley
New York
| – | -$32.4K | -271 | Closed |
|
|
U
11
UBS
Zurich,
Switzerland
| – | -$14K | -100 | Closed |
|
12
Ameriprise
Minneapolis,
Minnesota
| – | +$239 | +2 | New |
|